A recent yearly report on marijuana sector employment in the United States reveals a nearly 5% increase in full-time cannabis jobs over the past year, marking a turnaround from the approximately 2% decline compared to 2022. Despite this increase, it represents the smallest annual growth since 2017. According to the report by Vangst, a Colorado-based … Continue reading “420 with CNW — Report Shows the US Cannabis Industry Now Employs 440,000 Full-Time”
A recently conducted Ipsos poll has found that one-half of Floridians would vote to approve an abortion ballot initiative. The poll included 316 independents, 264 Democrats, and 369 GOP members. It was carried out April 5–7, 2024, with a margin of error of 4.1%. The survey include more than 1,000 adults in Florida, determining that … Continue reading “Ipsos Poll Suggests Cannabis, Abortion Ballot Measures Not Certain of Success in Florida”
Germany recently passed a new law that decriminalizes marijuana possession and cultivation for personal use, permitting individuals over the age of 18 to possess up to 25 grams of marijuana and cultivate up to three plants for personal use. Beginning in July 2024, German citizens can also join cannabis grower’s associations or not-for-profit social clubs … Continue reading “420 with CNW — Why the UK Needs to Consider Decriminalizing Cannabis As Germany Just Did”
Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, was featured in the latest episode of the Bell2Bell Podcast as part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Bryan McLaren, chairman and CEO of Zoned Properties, joined the program to provide an overview … Continue reading “CannabisNewsBreaks – Zoned Properties Inc. (ZDPY) Featured in Bell2Bell Podcast”
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is announcing that Dr. David G. Morgan, PhD, a renowned leader in neurodegenerative disease, has joined its scientific advisory board (“SAB”). The announcement noted that the addition reinforces the company’s commitment to advancing its INM-901 program … Continue reading “CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Welcomes Leading Authority in Alzheimer’s Research to Scientific Advisory Board”
The BizCann Expo, produced and hosted by ZJ Events, today announced the next rendition of its premier cannabis confab. Set to take place at the sleek Plaza Mayor in Medellin, Colombia, from May 18-19, the expo follows a series of blowout events in both North and South America. BizCann Expo is among the world’s elite … Continue reading “CannabisNewsBreaks – BizCann Expo Colombia to Showcase Insights on Emerging Trends in Canna-Business Landscape”
The possession and use of cannabis is illegal under federal law in the United States. Despite this, many states across the country have legalized the drug for recreational or medical purposes. This comes as public support for legalization continued to increase. Below are some facts about cannabis in the United States, based on recent data. … Continue reading “Six Quick Facts About Cannabis and Americans”
Alternative Products Expo has announced the return of the world’s premier counterculture industry event to Medellín, Colombia. Another first-class production of ZJ Events, Vape South America Medellín 2024 is slated to take place at the Centro de Convenciones Plaza Mayor in Medellín from May 18-19, 2024. Strategically located with a welcoming atmosphere and great climate, … Continue reading “CannabisNewsBreaks – Vape South America Medellín 2024 to Showcase Innovation in Alternative Products Supply Chain”
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has received approval to begin a new human pilot study. The approval, which was granted by an independent third-party ethics review board, enables Lexaria to move forward with its plan to conduct a GLP-1 study investigating GLP-1 drugs and DehydraTECH(TM). According to the announcement, … Continue reading “CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Approval to Commence Human Pilot Study Evaluating GLP-1, DehydraTECH”
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids and proprietary cannabinoid analogs, is reporting on additional preclinical data for INM-089, a proprietary small molecule compound acting as a preferential signaling ligand of cannabinoid receptor 1 (“CB1”) and cannabinoid receptor 2 (“CB2”). The reported data continues to demonstrate … Continue reading “CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD”
